Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (8395)	3/5/1998 10:29:00 PM
From: DMore	Read Replies (3) \| Respond to of 14328

Very good Scott. One other omission was the $2 million in R&D for the year. Sooner or later this will start falling to the bottom line. I hope 30% for year is exceeded in bottom line results for '98. Only .08-.09 for the year would be disastrous. Bottom line results have got to improve very soon. We need to see .03+ in the 1st qtr. with 30% qtr. over qtr. growth. This would really get some notice and should not be that hard to achieve. 1st qtr. .03 2nd qtr. .04 3rd qtr. .052 4th qtr. .067 Year .189 Not Bad! Shares were up about 500,000 from previous qtr. About 300,000 warrants were exercised, so only a little more dilution. It is still difficult to explain where all the selling has been coming from at $2 and below. Good ridence L/H!!!!!! D